The healthcare landscape is primed and ready for consumers to have better control of their own health. With patients regularly facing significant out of pocket costs for diagnostic testing, combined with a poor user experience in trying to access the healthcare system, Nathalya Mamane, CEO and Founder of RT MicroDx, is stepping forward to leverage technology and provide an improved standard of care.

In this episode, we discover how her startup is tackling testing issues head on. The company’s beachhead product is targeting Strep Throat, a common bacterial infection that affects millions of people every year. Despite its frequency, K Health reported that the cost of a strep test in the US averages $270 at a doctor’s office without insurance.

RT MicroDx is looking to provide molecular testing from the comfort of your home, to make the test quicker and more efficient, meaning it will be more accessible for patients, leading to a more equitable system for all.

As a non-technical founder, Nathalya’s journey is one that can be a shining light for other entrepreneurs looking to make an impact in the medtech space. She is demonstrating that by tapping into the startup ecosystem, and implementing a robust Go-to-Market strategy, it is possible to bring innovative solutions to patients without prior technical experience.

Nathalya’s passion for solving a problem faced by millions of people shines through in this discussion. To overcome a challenging fundraising climate, she has preserved and continued to build value through strategic thinking, iterative development, and creating a strong network. This is truly a wonderful conversation with a great founder, so tune in so you can be equally informed and inspired!